NewBiologix’s Post

We are very pleased to announce that our CEO, Eric Halioua will be on stage today in a panel at the Cell Therapy Manufacturing & Gene Therapy Congress organized by Informa in Dublin, Ireland. At 11:30 Eric, accompanied by Imen Mestiri, Thibault Jonckheere, and George Frodsham, will address Partnership Challenges in Cell & Gene Therapy as the market conditions change. What will be discussed? - Exploring the impacts of market conditions on CGT partnerships. - Understanding the evolving landscape of collaboration between small innovators and large biotechs. - Evaluating current partnership strategies and how they can be improved. https://lnkd.in/eeWBzXk

The #conference year is slowly coming to an end. I think this is one of the last stops for Coriolis Pharma and a good opportunity to discuss with our #team. 🕚 If you are in #AAV, #Lentivirus and any other #viralvector #development and/or #characterization, make sure to get an appointment with Evelyn Eggenstein and Jörg Müller in Hashtag #Boston. 📞 If you are not in Boston, fine as well. Approach us directly via #LinkedIn 📧 or read more about viral vectors on our #homepage 🖥: https://lnkd.in/d_HhVPgm

Our Accelerating Science Cell & Gene Therapy Feature is now live, showcasing lab product reviews by scientists like you. Explore top reviews on key technologies from gene editing to manufacturing. Share your own review for a chance to be featured and recommend valuable products to peers: https://lnkd.in/d5FcAFZ #celltherapy #genetherapy #sciencecommunication #reviews #labproducts #geneediting

If you are not watching it right now, register and access the recordings later, this is definitely worth listening to. Fascinating topics. Valuable insights and business-minded outlook. Each session highlights the current landscape, gets right to the heart of the existing issues and identifies the most promising ways forward.

Join us tomorrow morning for our next #painresearch webinar presented by Dr. Ana Moreno, Co-Founder and CEO of Navega Therapeutics. She'll discuss a novel #epigenetic gene therapy that targets NaV1.7. She'll also discuss how epigenetic gene therapies can be utilized to target previously undruggable targets, such as Nav1. #TranslationalTuesday #earlyhumaninsights   #drugdiscovery

Our Accelerating Science Cell & Gene Therapy Feature is now live, showcasing lab product reviews by scientists like you. Explore top reviews on key technologies from gene editing to manufacturing. Share your own review for a chance to be featured and recommend valuable products to peers: https://lnkd.in/d5FcAFZ #celltherapy #genetherapy #sciencecommunication #reviews #labproducts #geneediting

In the cell and gene therapy industry's recent performance, what has been most impressive is the series of historical firsts reported in just three months, from December 2023 to the end of February 2024. This includes： 1.the first-ever CRISPR/Cas9 gene editing treatment product, CASGEVY™, which has been approved for market in the United States, United Kingdom, European Union, Saudi Arabia, and Bahrain； 2.the first T-cell therapy for solid tumors, AMTAGVI™, which received FDA approval in the United States. However, the market's investment does not seem to reflect these achievements well. These significant breakthroughs often require longer times to reach the market than traditional drugs, and the accessibility and affordability for patients pose significant challenges. These continue to challenge the ongoing development of the field.

🤔💡 Do you think qPCR assays can be transferred to dPCR with minimal optimization? Yes they can! Check out the AAV quantitation and characterization workflow described in Advancing Successful Gene Therapy Development – a QIAGEN and Pharma Intelligence eBook. The duplex dPCR probe assay amplifies both a backbone target and a gene of interest with demonstrated reproducibility. Download the eBook ➡️ https://lnkd.in/eXZvWShm #digitalPCR #dpcr #AAVvector #genetherapy #celltherapy

Accurate measurement of viral titer is key to avoiding under- and overdosing of gene therapy products, but methods for viral titer determination have come a long way since the earliest days of gene therapy. This article from BioInsights explores traditional approaches to measuring viral titer and the continued evolution of techniques and technology in the field. Read it here: https://ow.ly/EEBv50Qf89u #GeneTherapy #ViralTiter

Our Accelerating Science Cell & Gene Therapy Feature is now live, showcasing lab product reviews by scientists like you. Explore top reviews on key technologies from gene editing to manufacturing. Share your own review for a chance to be featured and recommend valuable products to peers: https://lnkd.in/d5FcAFZ #celltherapy #genetherapy #sciencecommunication #reviews #labproducts #geneediting